Skip to main navigation menu Skip to main content Skip to site footer

Case Report

Vol. 3 No. 1 (1997)

Case Report: Carcinoembryonic Antigen (CEA) in Postoperative Follow-up and Treatment Monitoring of Colorectal Adenocarcinoma

  • K.S. Price, M.D.
  • D.M.P. Thomson, M.D., Ph.D., F.R.C.P.(C)
DOI
https://doi.org/10.26443/mjm.v3i1.474
Submitted
November 1, 2020
Published
2020-12-01

Abstract

N/A

References

  1. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. Journal of Experimental Medicine 122: 467; 1965.
  2. Thomson DM, Krupey J, Freedman SO, et al. The radioimmunoassay of circulating carcinoembryonic antigens of the human digestive system. Proceedings of the National Academy of Sciences USA 64(1): 161- 167; 1969.
  3. Goldenberg DM, Neville AM, Carter AC, et al. CEA (carcinoembryonic antigen): its role as a marker in the management of cancer. Journal of Cancer Research and Clinical Oncology 101(3): 239-242; 1981.
  4. Lo Gerfo PJ, Herter FP. Carcinoembryonic antigen and prognosis in patients with colon cancer. Annals of Surgery 181(1): 81-84; 1975.
  5. Wolmark N, Fisher B, Wieand HS, et al. The prognostic significance of preoperative carcinoembryonic antigen levels in colorectal cancer. Results from NSABP (National Surgical Adjuvant Breast and Bowel Project) clincial trials. Annals of Surgery 199(4): 375-382; 1984.
  6. Tormey DC, Waalkes TP. Clinical correlation between CEA and breast cancer. Cancer 42(3 Suppl): 1507- 1511; l978.
  7. Molina R, Filella X, Pique JM, et al. Application of the tumor markers CEA and CA 19-9 in the early diagnosis of recurrence of colorectal cancer. Neoplasia 6: 156-158; 1989.

Metrics

Metrics Loading ...